What is the price target for RYAN stock?
25 analysts have analysed RYAN and the average price target is 52.38 USD. This implies a price increase of 39.87% is expected in the next year compared to the current price of 37.45.
NYSE:RYAN • US78351F1075
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RYAN SPECIALTY HOLDINGS INC (RYAN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-14 | B of A Securities | Maintains | Buy -> Buy |
| 2026-04-13 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-04-09 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2026-04-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-04-09 | JP Morgan | Maintains | Underweight -> Underweight |
| 2026-04-08 | UBS | Maintains | Buy -> Buy |
| 2026-04-08 | Barclays | Maintains | Overweight -> Overweight |
| 2026-04-08 | Goldman Sachs | Maintains | Buy -> Buy |
| 2026-04-07 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2026-04-06 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-03-23 | Citigroup | Maintains | Buy -> Buy |
| 2026-03-17 | RBC Capital | Reiterate | Outperform |
| 2026-03-11 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-27 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-02-25 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2026-02-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-02-17 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2026-02-17 | UBS | Maintains | Buy -> Buy |
| 2026-02-13 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2026-02-13 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-13 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-01-14 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2026-01-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-08 | Barclays | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.078B 20.42% | 2.516B 21.09% | 3.051B 21.28% | 3.467B 13.63% | 3.9B 12.49% | 4.385B 12.44% | 5.427B 23.76% | N/A | N/A | |
| EBITDA YoY % growth | 582.127M 19.58% | 776.884M 33.46% | 899.624M 15.80% | 1.108B 23.16% | 1.255B 13.27% | 1.465B 16.73% | 1.904B 29.97% | N/A | N/A | |
| EBIT YoY % growth | 466.29M 23.52% | 609.254M 30.66% | 612.109M 0.47% | 776.59M 26.87% | 904.21M 16.43% | 982.31M 8.64% | 1.529B 55.65% | N/A | N/A | |
| Operating Margin | 22.44% | 24.22% | 20.06% | 22.40% | 23.18% | 22.40% | 28.17% | N/A | N/A | |
| EPS YoY % growth | 1.38 20.00% | 1.79 29.71% | 1.97 10.06% | 2.31 17.41% | 2.69 16.33% | 3.12 15.93% | 3.92 25.57% | 4.41 12.50% | 4.96 12.50% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.45 15.00% | 0.76 15.65% | 0.56 19.13% | 0.54 18.92% | 0.55 22.88% | 0.91 18.66% | 0.67 20.03% | 0.65 21.83% | 0.63 15.21% | 1.02 13.12% | 0.73 9.12% | 0.74 13.90% |
| Revenue Q2Q % growth | 802.21M 16.23% | 976.87M 14.23% | 862.94M 14.36% | 863.34M 14.93% | 912.12M 13.70% | 1.09B 11.58% | 972.19M 12.66% | 968.1M 12.13% | 1.023B 12.16% | 1.239B 13.67% | 1.078B 10.88% | 1.092B 12.80% |
| EBITDA Q2Q % growth | 226.36M 13.87% | 343.06M -4.92% | 264.96M -25.43% | 259.35M -36.19% | 262.67M 16.04% | 390.74M 13.90% | 302.55M 14.19% | 297.14M 14.57% | 294.98M 12.30% | 434.83M 11.28% | 332.11M 9.77% | 319.16M 7.41% |
| EBIT Q2Q % growth | 129.68M -1.14% | 248.65M 12.70% | 167.11M 18.22% | 165.76M 39.35% | 164.41M 26.78% | 292.26M 17.54% | 203.81M 21.96% | 207.47M 25.16% | N/A | N/A | N/A | N/A |
All data in USD
25 analysts have analysed RYAN and the average price target is 52.38 USD. This implies a price increase of 39.87% is expected in the next year compared to the current price of 37.45.
RYAN SPECIALTY HOLDINGS INC (RYAN) will report earnings on 2026-04-30, after the market close.
The consensus EPS estimate for the next earnings of RYAN SPECIALTY HOLDINGS INC (RYAN) is 0.45 USD and the consensus revenue estimate is 802.21M USD.
The number of analysts covering RYAN SPECIALTY HOLDINGS INC (RYAN) is 25.